These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cervical cytology screening in HIV-positive women: completion of the audit cycle. Bates SM; Street EJ Int J STD AIDS; 2011 Oct; 22(10):615-6. PubMed ID: 21998191 [No Abstract] [Full Text] [Related]
4. Secondary prevention of cervical cancer. Basu P; Mittal S; Bhadra Vale D; Chami Kharaji Y Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():73-85. PubMed ID: 28988647 [TBL] [Abstract][Full Text] [Related]
5. The future of the Pap: where is cervical cancer screening headed? Ruhl C Nurs Womens Health; 2008 Oct; 12(5):427-31. PubMed ID: 18837722 [No Abstract] [Full Text] [Related]
6. Liquid-based cytology: the new screening test for cervical cancer control. McGoogan E J Fam Plann Reprod Health Care; 2004 Apr; 30(2):123-5. PubMed ID: 15087002 [No Abstract] [Full Text] [Related]
8. Clinical implications of transitioning from cytology to human papillomavirus-based cervical cancer screening. Hammer A; Gravitt P Acta Obstet Gynecol Scand; 2021 Mar; 100(3):371-372. PubMed ID: 33739440 [No Abstract] [Full Text] [Related]
9. Is it time to introduce HPV self-sampling for primary cervical cancer screening? Petignat P; Vassilakos P J Natl Cancer Inst; 2012 Feb; 104(3):166-7. PubMed ID: 22271766 [No Abstract] [Full Text] [Related]
10. The economics of screening. Stewart CJ Cytopathology; 1997 Jun; 8(3):211. PubMed ID: 9202898 [No Abstract] [Full Text] [Related]
12. Toward objective cervical cancer screening: maybe the eyes do have it. Stoler MH Am J Clin Pathol; 2010 Jul; 134(1):5-6. PubMed ID: 20551259 [No Abstract] [Full Text] [Related]
13. Establishment of a national cervical screening programme in Ireland, CervicalCheck: the first 6 years. Flannelly GM; Mooney MT; Greehy GM; Keogh EB; McNally SA; Fitzpatrick PE Eur J Cancer Prev; 2018 Mar; 27(2):158-163. PubMed ID: 27824660 [TBL] [Abstract][Full Text] [Related]
14. Cervical screening: what is the point? Denton KJ Lancet; 1995 Jul; 346(8969):244; author reply 246-7. PubMed ID: 7616809 [No Abstract] [Full Text] [Related]
15. Evidence-based, alternative cervical cancer screening approaches in low-resource settings. Sherris J; Wittet S; Kleine A; Sellors J; Luciani S; Sankaranarayanan R; Barone MA Int Perspect Sex Reprod Health; 2009 Sep; 35(3):147-54. PubMed ID: 19805020 [No Abstract] [Full Text] [Related]
16. New tests for cervical cancer screening. Apgar BS Am Fam Physician; 2001 Sep; 64(5):729-30, 732. PubMed ID: 11563564 [No Abstract] [Full Text] [Related]
17. The equivocal Pap test: its past, present, and future. Selvaggi SM Diagn Cytopathol; 2010 Jul; 38(7):471-2. PubMed ID: 19941377 [No Abstract] [Full Text] [Related]
18. Expanded use of human papillomavirus testing in gynecologic practice. Lee SH Am J Clin Pathol; 2007 Nov; 128(5):883-4; author reply 884-6. PubMed ID: 18018331 [No Abstract] [Full Text] [Related]
19. Tests for atypical squamous cells of undetermined significance. Budenholzer B JAMA; 2006 Mar; 295(11):1247; author reply 1247-8. PubMed ID: 16537730 [No Abstract] [Full Text] [Related]
20. Accuracy of the Papanicolaou test in the detection of high-grade cervical lesions. Repše-Fokter A Int J Gynaecol Obstet; 2011 Jan; 112(1):65-6. PubMed ID: 21056413 [No Abstract] [Full Text] [Related] [Next] [New Search]